CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
SUNDAY 04 SEPTEMBER, 2016
OA1528
OA1529
RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
Jie Zhang (Changchun, China), Jie Zhang, Xuejiao Lv, Yuqiu Hao, Qi Wang, Guangping Meng, Lin Zhang, Zhenzhong Su
IL-17C promotes tumor-associated inflammation and lung tumor growth
Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Lina Bittigkoffer, Andreas Kamyschnikow, Christian
Herr, Robert Bals, Christoph Beisswenger
OA6020
Cell intrinsic and environmental factors influencing human bronchial epithelial cell migration
Fraser Millar (London, United Kingdom), Fraser Millar, Kate Gowers, Robert Hynds, Jessica Eley, Rachel Chambers, Sam
Janes, Adam Giangreco
Room ICC Capital Suite
11
Session 248 14:45 - 16:45
Poster Discussion: How the increasing complexity of chronic care management challenges ethics
and costs in our healthcare system
Chairs : Christopher Michael Roberts (Leytonstone, United Kingdom), Sylvia Hartl (WIEN, Austria)
PA1530
PA1531
PA1532
PA1533
PA1534
PA1535
PA1536
PA1537
PA1538
PA1539
Dupilumab reduces severe exacerbation-related costs among asthma patients: Results from a phase 2b trial
Jonathan Corren (Los Angeles, United States of America), Jonathan Corren, Pascal Chanez, Mario Castro, Leonardo Fabbri,
Vijay N. Joish, Robert E. Evans, Neil M.H. Graham, Vera Mastey, Sara Villeneuve, Gaëlle Bégo-Le Bagousse, Christine
Taniou, Puneet Mahajan, Ariel Teper, Gianluca Pirozzi, Laurent Eckert
Cost impact of a multidisciplinary clinic for children with problematic severe asthma
Karen Kam (Calgary, Canada), Karen Kam, Alberto Nettel-Aguirre, Ian Mitchell, David Johnson, Gillian Currie
Decision analytic models in COPD/asthma: A critical review of current evidence
Vaibhav Gaur (Mumbai, India), Vaibhav Gaur, Jaideep Gogtay, Probit Ghosh
Modelling cost effectiveness of a COPD pathway using the Star approach; could cognitive behavioural therapy
(CBT) be cost effective in preventing panic-associated admissions?
Richard Hall (Durham, United Kingdom), Richard Hall, Richard Glover, Richard Harrety
Analysis of driving factors of willingness to use and willingness to pay for existing pharmacological smoking cessation
aids among young and middle-aged adults in Germany
Marina Treskova (Hannover, Germany), Marina Treskova, Ines Aumann, Niklas Hagemann, J.-Matthias Graf von der
Schulenburg
Hospitalization cost analysis due to acute COPD exacerbations
Bojana Trivic (Novi Sad, Republic of Serbia), Bojana Trivic, Biljana Zvezdin, Tomi Kovacevic, Violeta Kolarov, Olivera
Maksimovic
The health economics of treating MDR-TB in the Indian private sector
Jai Mullerpattan (Mumbai (Maharastra ), India), Zal Udwadia, Jai Mullerpattan, Radhika Banka, Shashank Ganatra, Zarir
Udwadia
Nasal high flow therapy in palliative home care
Annegret Kamp (Homburg (Saar), Germany), Annegret Kamp, Franziska Trudzinski, Frederik Seiler, Oliver Linn, Carlos
Metz, Konstantinos Tsitouras, Robert Bals, Heinrike Wilkens, Sebastian Fähndrich, Philipp Lepper
End-of-life care decisions in a pediatric respiratory unit
Uros Krivec (Ljubljana, Slovenia), Uros Krivec, Marina Praprotnik, Malena Aldeco, Dusanka Lepej, Ana Kotnik,
Aleksandra Zver, Tita Butenko, Majda Benedik Dolnicar, David Neubauer
Facing death in a respiratory ward
Vânia Catarina Pereira Caldeira (Azueira, Portugal), Vânia Catarina Pereira Caldeira, Tiago Sá, Nicole Murinello, Delmira
Pombo, João Cardoso
PA1540
Improvement science: Education in Europe
Radu Adrian Crisan-Dabija (Iasi, Romania), Radu Crisan, Traian MIhaescu
Room ICC Capital Suite
12
Session 249 14:45 - 16:45
Poster Discussion: Possible phenotypes of bronchiectasis and exacerbations
Chairs : Francesco Blasi (Milano, MI, Italy), Felix C. Ringshausen (Hannover, Germany)
107 26.08.2016